Skip to main content
PMC home page
Elsevier Sponsored Documents logoLink to Elsevier Sponsored Documents
. 2015 Jan 15;159:36–42. doi: 10.1016/j.jep.2014.10.012

Screening of Vietnamese medicinal plants for NF-κB signaling inhibitors: Assessing the activity of flavonoids from the stem bark of Oroxylum indicum

Thi Van Anh Tran a,c, Clemens Malainer b, Stefan Schwaiger a,⁎, Tran Hung c, Atanas G Atanasov b, Elke H Heiss b, Verena M Dirsch b, Hermann Stuppner a
PMCID: PMC4292993  PMID: 25456439

Abstract

Ethnopharmacological relevance

Seventeen plants used in Vietnamese traditional medicine for the treatment of inflammatory disorders were screened for NF-κB inhibitory activity. Oroxylum indicum, which exhibited activity, was investigated in detail.

Materials and methods

Forty plant extracts from 17 species were prepared by maceration using dichloromethane and methanol and were tested (10 µg/mL) to evaluate their ability to inhibit NF-κB activation using TNF-α-stimulated HEK-293 cells stably transfected with a NF-κB-driven luciferase reporter. The active extract of Oroxylum indicum was subsequently fractionated by different chromatographic techniques. After isolation, all single compounds were identified by spectroscopic methods and assessed for NF-κB inhibitory effects.

Results

The dichloromethane extracts obtained from Chromolaena odorata leaves and the stem bark of Oroxylum indicum showed distinct inhibitory effects on NF-κB activation at a concentration of 10 µg/mL. The active extract of Oroxylum indicum was subjected to further phytochemical studies resulting in identification of four flavonoid aglyca and six flavonoid glycosides. Pharmacological evaluation of the obtained compounds identified oroxylin A as the most active substance (IC50=3.9 µM, 95% CI: 3.5–4.4 µM), while chrysin and hispidulin showed lower activity with IC50=7.2 µM (95% CI: 6.0–8.8 µM) and 9.0 µM (95% CI: 7.9–10.2 µM), respectively. Interestingly, in this study the activity of baicalein (IC50=28.1 µM, 95% CI: 24.6–32.0 µM) was weak. The isolated glycosides showed no inhibitory activity when tested at a concentration of 30 µM. Quantification of the four active flavonoids in extracts and plant materials suggested that oroxylin A contributes to the NF-κB inhibitory activity of the stem barks of Oroxylum indicum to a greater extent than baicalein which was thought to be responsible for the anti-inflammatory activity of this plant.

Conclusions

The screening presented in this study identified the dichloromethane extracts of Chromolaena odorata and Oroxylum indicum as promising sources for NF-κB inhibitors. Hispidulin, baicalein, chrysin and oroxylin A, isolated from Oroxylum indicum, were identified as inhibitors of NF- κB activation.

Keywords: NF-κB, Oroxylum indicum, Hispidulin, Baicalein, Chrysin, Oroxylin A

Graphical abstract

graphic file with name fx1.jpg

Open in a new tab

1. Introduction

Inflammation is a response of organisms to the presence of pathogens and chemical or mechanical injury. Although it is a defense mechanism, the complex events and mediators in the uncontrolled inflammation reaction can induce or sustain a pathologic process involved in different diseases e.g. arthritis, atherosclerosis, allergy, the metabolic syndrome, sepsis and auto-immune diseases as well as cancer (Libby et al., 2002; Allavena et al., 2008). Initiation and promotion of inflammatory processes require synthesis of effector proteins such as cell adhesion molecules (VCAM-1, ICAM-1), inducible enzymes (COX-2 and iNOS), chemokines (MCP-1, MIP-1α), cytokines and growth factors (tumor necrosis factor alpha (TNF-α), interleukins) (Sacca et al., 1997; Eppihimer, 1998). Thus, one strategy to block inflammation is to inhibit inflammatory mediators on the transcriptional level. Among the involved transcription factors, nuclear factor kappa B (NF-κB) plays a prominent role. Therefore, the NF-κB signaling pathway represents an established target for anti-inflammatory drug discovery (Sun and Andersson, 2002; Gupta et al., 2010). Besides synthetic compounds, several natural products have been identified to inhibit NF-κB (Bremner and Heinrich, 2002, 2005; Calixto et al., 2003; Gupta et al., 2010; Baumgartner et al., 2011).

In Vietnam, traditional medicine has a long established history and plays an important role in the health care system. Vietnam׳s territory with an area of more than 3,30,000 square kilometers has a number of key ecosystems including a variety of marine and coastal habitats, wetland, and two important river deltas and is known as a hot spot of biodiversity covering more than 12,000 plant species (Nguyen et al., 2007). Many of these plants have been used to treat diseases and traditional knowledge is still preserved. In 2009, Nguyen and You screened 87 plants used in Vietnamese traditional medicine for inhibitory activity on NF-κB activation and identified seven methanolic extracts as potential inhibitors of this pathway. In a continuing effort to rationalize and assess the activity of medicinal plants in Vietnam for inflammatory diseases, we conducted a screening of 17 plants which are listed in the textbook “Medicinal plants and animals in Vietnam (National Institute of Medicinal Materials, 2004)”. Two of the plant extracts showed promising inhibitory activity on NF-κB activation: the dichloromethane extracts of Oroxylum indicum and Chromolaena odorata. In 2010, Siriwatanametanon et al. found that the ethyl acetate extract of Oroxylum indicum possesses NF-κB inhibitory activity; however, identification of the responsible compound(s) was not described.

2. Materials and methods

2.1. Plant material

The plant material used in this study was collected from different locations in the south of Vietnam between March and September 2010. The collected species were identified and authenticated by taxonomists from the Department of Pharmacognosy, Faculty of Pharmacy, University of Medicine and Pharmacy of HoChiMinh city. Voucher specimens of plants are deposited in the herbarium of the Pharmacognosy Department at University of Medicine and Pharmacy of HoChiMinh city (Table 1). Additional samples of the stem bark of Oroxylum indicum were collected in CuChi (sample Oro-1), in the botanical garden of Faculty of Pharmacy (HoChiMinh city; sample Oro-2), while sample Oro-3 and Oro-4 were collected in BinhPhuoc. All plant samples were air-dried and finally ground to a fine powder before further processing.

Table 1.

Latin names, plant parts and traditional uses of selected plant species in the screening for NF-κB inhibitors.

Latin name Family Plant part Voucher specimen Traditional uses (National Institute of Medicinal Materials, 2004)
Abutilon indicum (L.) Sweet Malvaceae Aerial part DN101 Treatment of fever, rheumatism, dysuria, carbuncle
Achyranthes aspera L. Amaranthaceae Root, aerial part DN102 Treatment of rheumatism, contusion, osteodynia, dysuria
Barleria lupulina Lindl. Acanthaceae Aerial part DL101 Treatment of snake-bites, bleeding wounds, rheumatism
Coptosapelta tomentosa (Blume) Vahl.ex Heyne var. dongnaiensis (Pit.) Phamh. Rubiaceae Stem, root KH081 Treatment of bleeding wounds, contusion or used as a tonic
Dischidia rafflesiana Wall. Asclepiadaceae Pitcher-shaped leaf PQ101 Treatment of rheumatism, snake-bites, jaundice or used as a tonic
Drynaria quercifolia (L.) J.Sm. Polipodiaceae Rhizome DN103 Treatment of rheumatism, osteodynia, dentagia
Chromolaena odorata (L.) syn.: Eupatorium odoratum L. King et Robinson Asteraceae Aerial part LA103 Treatment of diarrhea, rheumatism, burns, skin wounds
Ficus pumila L. Moraceae Stem, leaf BMT101 Treatment of rheumatism
Gleditsia fera (Lour.) Merr. Caesalpiniaceae Thorn Treatment of carbuncle, osteodynia
Ipomoea biloba Forsk. syn.: Ipomoea pes-carprae (L.) Sweet Convolvulaceae Aerial part PT101 Treatment of fever, rheumatism, edema, snake-bites
Justicia gendarussa L. syn.: Gendarussa vulgaris Nees Acanthaceae Aerial part DL102 Treatment of osteodynia, rheumatism, jaundice, hives
Leea rubra Blume Leeaceae Root BT101 Treatment of rheumatism
Momordica cochinchinensis (Lour.) Spreng. Cucurbitaceae Seed DL103 Treatment of carbuncle, contusion, swelling
Oroxylum indicum (L.) Vent Bignoniaceae Stem bark Oro-1, Oro-2, Oro-3, Oro-4 Treatment of allergy, inflammation, jaundice
Parabarium micranthum (Wall.) Pierre ex Spire Apocynaceae Stem DN104 Treatment of rheumatism, osteodynia
Scoparia dulcis L. Scrophulariaceae Aerial part DN105 Treatment of diabetes, hypertension, sore throat, used as an antidote
Smilax glabra Roxb. Smilacaceae Rhizome DN106 Treatment of syphilis, acute and chronic nephritis, metal poisoning, rheumatism
Open in a new tab

2.2. Extraction

2.2.1. Preparation of extracts for screening

Finely ground plant material (5 g) was extracted with 50 mL dichloromethane by sonication for 10 min at room temperature. The plant material was recovered by filtration and the process was repeated three times with fresh solvent. The obtained solutions were combined and evaporated to dryness using a rotavapor to give dichloromethane extracts. The residual plant material was air-dried and subsequently extracted with methanol using the same procedure as described above to yield the corresponding methanol extracts. All dried extracts were dissolved in dimethyl sulfoxide (DMSO) prior to bioactivity evaluation.

2.2.2. Extraction of the stem bark of Oroxylum indicum for quantification purposes

Dried stem barks of Oroxylum indicum were cut into pieces and ground to a fine powder. The plant material (0.5 g) was extracted five times with 40 mL of methanol by sonication (15 min each, at ambient temperature) and then centrifuged at 3300 rpm for 7 min. Extracts were combined, evaporated under reduced pressure and subsequently re-dissolved in methanol, quantitatively transferred to a volumetric flask and adjusted to the final volume (10 mL) with methanol. Prior to injection, all solutions were filtered through cotton wool. Each sample solution was assayed in triplicate.

2.3. NF-κB activity and cell viability

HEK293/NF-κB-luc cells (Panomics, RC0014), a HEK293 cell line stably transfected with NF-κB luciferase reporter, were used to determine NF-κB activity and cell viability as previously described (Vogl et al., 2013). Briefly, cells were maintained at 37 °C and 5% CO2 atmosphere in Dulbecco׳s modified Eagle׳s medium (DMEM; Lonza, Basel, Switzerland) with 100 U/mL benzylpenicillin 100 μg/mL streptomycin, 2 mM glutamine, and 10% fetal bovine serum (FBS). Before seeding in 96-well plates, cells were stained for 1 h in serum-free medium supplemented with 2 μM Cell Tracker Green CMFDA (Invitrogen), a fluorescent probe that is retained inside living cells and thus can be used to monitor cell membrane integrity and cell viability (Markasz et al., 2007; Stern et al., 2008; Johnson-Lyles et al., 2010; Vogl et al., 2013). Cells were then plated in 96-well plates (4×104 cells/well) in phenol red-free and FBS-free DMEM overnight. The following morning, cells were pretreated with the investigated samples, positive control (parthenolide, 10 or 5 µM; IC50 value: 1.5 µM, 95% CI 1.3–1.8 µM) or solvent vehicle (0.1% DMSO in culture medium) for 30 min and stimulated with 2 ng/mL TNF-α for 4 h. Afterwards, the cells were lysed with a luciferase lysis buffer (Promega; E1531) and the luminescence of the firefly luciferase and the fluorescence of the Cell Tracker Green CMFDA were measured with a Genios Pro plate reader (Tecan, Grödig, Austria). For quantification of NF-κB activity, the luciferase-derived signal from the NF-κB reporter was normalized by the fluorescence signal derived from Cell Tracker Green CMFDA to account for differences in the cell number. Potential differences in viable cell numbers were detected by comparison of the Cell Tracker Green CMFDA fluorescence of the solvent vehicle treated cells and cells treated with the investigated samples.

2.4. Statistical analyses

Nonlinear regression (with sigmoidal dose response) was used to calculate the IC50 values using GraphPad Prism® 4.03 (GraphPad Software, Inc.). Statistical differences were compared with ANOVA with Tukey׳s post-hoc test. P values<0.05 were considered to be significant.

2.5. Chromatography and NMR analysis

Fast Centrifugal Partition Chromatography (FCPC) (Kromaton, France) was equipped with Gilson 302/803 C pump system model 302 (Villiers-la-Bel, France).

LC for quantification—LC-parameter: HP 1090 system (Agilent, Waldbronn, Germany) equipped with autosampler, DAD and column thermostat; stationary phase: Zorbax SB-C18 column (150×4.6 mm, 3.5 µm particle size); mobile phase: solvent A: H2O with 0.5% formic acid (v/v); solvent B: methanol; DAD: 275 nm, temp.: 40.0 °C; injection volume: 5 μL; flow: 0.3 mL/min; composition during run: start: 40% B; 37 min: 70% B; 50 min: 75% B; 51 min: 98% B; 60 min: stop; post-time: 10 min.

LC–MS—LC-parameter: HP 1100 system (Agilent, Waldbronn, Germany) was equipped with auto-sampler, DAD and column thermostat. MS-parameters: Esquire 3000plus (Bruker Daltonics, Bremen, Germany); ESI, temperature: 350 °C; dry gas: 10.00 L/min; nebulizer 40 psi; full scan mode: m/z 100–1500.

NMR: 1D- and 2D-experiments were measured on a Bruker DRX 300 (Bruker Biospin Rheinstetten, Germany) operating at 300.13 MHz (1H) and 75.47 MHz (13C) at 300 K (chemical shifts δ in ppm, coupling constants J in Hz); NMR solvent: MeOH-d4 or DMSO-d6 with 0.03% TMS (Eurisotop Gif-Sur-Yvette, France), which was used as an internal standard.

2.6. Extraction, purification and identification of pure compounds from Oroxylum indicum

Dried stem barks of Oroxylum indicum (Oro-1) (100 g) were ground to a fine powder and extracted with 500 mL methanol at room temperature (10 times). After removal of the solvent under reduced pressure, the resulting crude extract (16.10 g) was suspended in 300 mL of H2O and successively extracted with petroleum ether (300 mL×4), ethyl acetate (300 mL×4) and water saturated n-BuOH (300 mL×4). The resulting extracts were concentrated under reduced pressure, to give petroleum ether (0.72 g), ethyl acetate (0.85 g), n-butanol (2.74 g) and water (11.24 g) extracts. The ethyl acetate extract (0.85 g) was subjected to silica gel (40–63 μm, Merck, Darmstadt, Germany; 100 g) column chromatography, using a CH2Cl2/MeOH gradient with increasing amounts of MeOH as mobile phase. The eluate was monitored by TLC and combined to 19 fractions (O.E1 – O.E19). Fraction O.E3 (CH2Cl2/MeOH, 99.7: 0.3) was recrystallized in CH2Cl2 to yield compound 1 (37.62 mg). Fraction O.E7 (CH2Cl2/MeOH, 99.5: 0.5; 35.46 mg) was purified by Sephadex LH-20 column chromatography using MeOH as mobile phase, yielding 15.44 mg of compound 2. Fraction O.E11 (CH2Cl2/MeOH, 97: 3; 91.24 mg) was rechromatographed by Sephadex LH-20 column chromatography using MeOH as mobile phase, yielding 8 fractions (OE.11.1 – OE.11.8) and compound 3 in fraction O.E11.5 (31.25 mg). Compound 4 (4.69 mg) was obtained by separation of fraction OE.11.7 by Sephadex LH-20 column chromatography with MeOH as mobile phase.

Since the minor compounds of the ethyl acetate extract were also present in a higher amount in the n-butanol extract (verified by HPLC-MS-experiments), the isolation work was carried out using the n-butanol extract. The n-butanol extract was re-dissolved in methanol. The MeOH-soluble part was fractioned by Sephadex LH-20 column chromatography with MeOH as mobile phase to yield 10 fractions (OB.1–OB.10). Fraction OB.4 (338.60 mg) was purified by means of FCPC using a solvent mixture of chloroform, methanol, water (9.5:10:5, all v/v, lower phase:mobile phase) to yield compound 5 (26.68 mg) and compound 8 (13.59 mg). Subfraction OB.4.2 (28.70 mg) was further separated with Sephadex LH-20 column chromatography using a mixture of methanol and water (1+1, v/v) as mobile phase to obtain compound 10 (5.34 mg) and compound 7 (4.90 mg). The MeOH-insoluble part of the n-butanol extract was separated by FCPC using the solvent system ethyl acetate, ethylene glycol dimethyl ether and water (2:1:2, upper phase:mobile phase), yielding 11 fractions (OBI.1–OBI.11). Fraction OBI.2 (16.63 mg) and fraction OBI.5 (9.50 mg) were rechromatographed by Sephadex LH-20 column chromatography using a mixture of methanol and water (1:1, v/v) as mobile phase to afford compound 9 (8.91 mg) and compound 6 (3.55 mg), respectively (Fig. 1).

Fig. 1.

Fig. 1

Open in a new tab

Structures of compounds (1–10) isolated from the stem bark of Oroxylum indicum.

3. Results and discussions

3.1. NF-κB inhibitory activities of dichloromethane and methanol extracts of 17 Vietnamese medicinal plants

In a primary screen, 40 different extracts of 17 plants were analyzed for their potential to inhibit TNF-α induced NF-κB activation in HEK-293 cells at a concentration of 10 µg/mL. Results are presented in Fig. 2. Strongest inhibition of NF-κB activation was found for Chromolaena odorata (DCM extract of the leaves) and Oroxylum indicum (DCM extract of the stem bark). In contrast to a previous study (Nguyen and You, 2009) dichloromethane and methanol extracts of Smilax glabra at a concentration of 10 µg/mL did not show any effect, whereas the dichloromethane extract of Chromolaena odorata (at 10 µg/mL) was found to abrogate activation of NF-κB to a higher degree as the positive control (at 10 µM). In the study of Nguyen and You (2009) methanol extracts of both species exhibited some minor NF-κB inhibitory effects (<25% at 30 µg/mL). The rather strong effect of the dichloromethane extract of Chromolaena odorata in comparison to that of the methanol extract might be due to lipophilic constituents extractable by means of apolar solvents but not or only to some extent by polar ones. This is consistent with a recent investigation which identified six fatty acids as well as scutellarein tetramethyl ether from Chromolaena odorata (Tran et al., 2011) as inhibitors of NF-κB activation. Further differences in the obtained findings might be a result of discrepancies in preparation of extracts, the setup of the in vitro assay, the selected sample concentration, and varying contents of active substances in the plant raw material, depending on harvest time and other influences.

Fig. 2.

Fig. 2

Open in a new tab

Effect of plant extracts (10 µg/mL) on NF-κB activation in HEK-293/NF-κB-luc cells; negative control: cells were treated with solvent vehicle (DMSO, 0.1%) and stimulated with TNF-α (2 ng/mL); positive control: cells were treated with parthenolide (10 µM) and stimulated with TNF-α. AP=aerial part; R=roots; St=stems; L=leaves; R=roots; Se=seeds; Th=thorns. The first letters of genus and species name of each plant were used to abbreviate plant names; see Table 1 for full names. Data points represent mean±S.E.M.; n=3, *p<0.05 (ANOVA/Tukey) compared with negative control.

NFκB inhibitory effects of the ethyl acetate extract of Oroxylum indicum were already reported by Siriwatanametanon et al. (2010), but the active principles were not determined. In the present study the dichloromethane extract of Oroxylum indicum was investigated and identified also as an inhibitor of NF-κB activation. Thus, both dichloromethane and ethyl acetate extracts were subjected to further phytochemical analysis.

3.2. Isolation of single constituents from the active fraction of Oroxylum indicum

Fig. 3 shows HPLC-DAD chromatograms of dichloromethane and ethyl acetate extracts of the stem bark of Oroxylum indicum. Compounds 1–3 are the main constituents of both extracts, while compounds 4–8 were not present in the dichloromethane extract. Therefore, a large scale ethyl acetate extract was prepared. Since compounds 5–8 were found in higher amounts in the n-butanol extract, isolation of these compounds was conducted using the n-butanol extract. After several purification steps by means of silica gel column chromatography, gel-filtration chromatography and counter-current chromatography, four flavonoid aglyca (1–4) could be isolated from the ethyl acetate extract and six flavonoid glycosides from the n-butanol extract (5–10). 1H and 13C NMR, as well as the 2-D-NMR data of compounds 1–8 were compared to literature data and found to be in good agreement with reported values (Mat Ali et al., 1998; Chen et al., 2003; Wu et al., 2005; Yadav et al., 2012). Based on NMR data and molecular weight determined by HPLC-MS, compounds 9 and 10 were identified as two methyl ester derivatives of compounds 5 and 8, respectively. 13C NMR data of compounds 9 and 10 are shown in Supplementary information together with the 1H NMR-spectra of compounds 1–4. Structures of isolated compounds (1–10) are shown in Fig. 1.

Fig. 3.

Fig. 3

Open in a new tab

HPL chromatograms of (A) dichloromethane extract and (B) ethyl acetate extract monitored at wavelength of 275 nm; for HPLC conditions see Section 2. Compound assignment: 1—Oroxylin A; 2—Chrysin; 3—Baicalein; 4—Hispidulin; for other compounds see Fig. 1.

3.3. Analysis of the NF-κB inhibitory effect of isolated compounds from Oroxylum indicum

Ten isolated compounds from the bark of Oroxylum indicum were analyzed in an NF-κB assay at a concentration of 30 µM. No decrease in cell viability within the used experimental setup could be observed. Interestingly, only the four flavonoid aglyca inhibited the NF-κB reporter gene transcription while the six flavonoid glycosides showed no significant activity (Fig. 4). The anti-inflammatory activity of compound 8, baicalin, which is the glycoside of baicalein has been previously studied in several in vivo tests. Cytoprotective properties against injury to the liver caused by ischemia/reperfusion (Kim et al., 2010) and neuroprotective effects against ischemic reperfusion injury in rats (Xue et al., 2010) were reported to be related to inhibition of NF-κB. However, in an interleukin-1β (IL-1β) induced human retinal pigment epithelial cell line (Nakamura et al., 2003), baicalin neither inhibited IL-1β-induced IL-6 and IL-8 protein and mRNA production, nor did this flavonoid inhibit activation of NF-κB. Herein, we conducted the NF-κB assay with baicalein and baicalin simultaneously to demonstrate clearly the difference in activity between the flavonoid aglycone and its glycoside derivative in vitro. The result showed that baicalein was active while its glycoside, baicalin, did not suppress NF-κB activity in the HEK293/NF-κB-luc cell system. The same phenomenon was also observed with the glycosides of chrysin and oroxylin A and their corresponding aglyca. The increase in polarity and molecular weight due to the sugar moiety which negatively influences the penetration of cell membranes could be one explanation for the loss of activity of the glycosides.

Fig. 4.

Fig. 4

Open in a new tab

Effect of isolated compounds (30 µM) on NF-κB activity in HEK-293/NF-κB-luc cells; negative control: cells were treated which solvent vehicle (DMSO, 0.1%) and stimulated with TNF-α; positive control: cells were treated with parthenolide (5 µM) and stimulated with TNF-α. For compound assignment see Fig. 1. Data points represent mean±S.E.M.; n=3, ⁎p<0.05 (ANOVA/Tukey) compared with negative control.

3.4. IC50 determination of the active flavonoids

In order to establish a preliminary structure-activity relationship and to assess the contribution of the four active flavonoids (hispidulin, baicalein, chrysin and oroxylin A) to the inhibitory effect on NF-κB activation of the Oroxylum indicum extract, IC50 values were determined. Oroxylin A was the most active substance (IC50=3.9 µM, 95% CI: 3.5–4.4 µM) while chrysin and hispidulin showed lower activity (IC50=7.2 µM, 95% CI: 6.0–8.8 µM, and 9.0 µM, 95% CI: 7.9–10.2 µM, respectively) in our cell based test system. Interestingly, baicalein revealed only a weak activity (IC50=28.1 µM, 95% CI: 24.6–32.0 µM) (Fig. 5). Baicalein, chrysin and oroxylin A are known for their anti-inflammatory effects attributed at least partially through the suppression of NF-κB activation (Chen et al., 2000; Kang et al., 2003; Ma et al., 2005; Shin et al., 2009; Sala et al., 2011) but this is the first time hispidulin was found to inhibit NF-κB activation. The results suggest that the presence of a hydroxyl group at the position 6 of the A ring (baicalein) reduces the activity of the flavone while a methoxyl group or no substitution at position 6 of the A ring (oroxylin A, hispidulin, chrysin) leads to a better inhibitory activity. Hispidulin possesses a similar structure to oroxylin A except for one additional hydroxyl group at position 4′ of the B ring. This modification results in a decrease of the ability to suppress NF-κB activation. These results supplement studies by Chen et al. (2004) who described the significance of hydroxyl groups at position 5 and 7 of the A ring and at position 4′ of the B ring for the effect of flavonoids in inhibiting ICAM-1, NF-κB and AP-1 activities on respiratory epithelial cells. Shin et al. (2011) studied the relationship among chalcone, flavanone, flavone and isoflavone derivatives and their inhibitory effect on TNF-α-induced NF-κB activation in HCT116 human colon cancer cell and emphasized the importance of hydroxyl substituents at C-5 position of the A ring of flavones.

Fig. 5.

Fig. 5

Open in a new tab

Dose–response curves and IC50 values of hispidulin, baicalein, chrysin and oroxylin A with respect to NF-κB activation.

3.5. Quantification of the active flavonoids (hispidulin, baicalein, chrysin and oroxylin A) in extracts and plant materials

Since baicalein was thought to be responsible for the anti-inflammatory activity of Oroxylum indicum, but showed only a weak NF-κB activity in this study, quantification of four flavonoids (hispidulin, baicalein, chrysin and oroxylin A) in the active extracts and stem bark materials was performed to get an idea about the contribution of each compound to the inhibitory effect on TNF-α-induced NF-κB activation. Validation of the established HPLC-DAD method is presented in Supplementary information. In the dichloromethane extract, hispidulin could not be determined; the contents of baicalein, chrysin and oroxylin A were 13.43%, 1.72%, 8.56% (w/w), respectively. These compounds were more abundant in the ethyl acetate extract: hispidulin (2.00%), baicalein (15.96%), chrysin (3.40%) and oroxylin A (13.85%, w/w). In both extracts the content of baicalein was higher than that of oroxylin A; however, the IC50 value of baicalein (IC50=28.1 µM) is almost 7 times higher than that of oroxylin A (IC50=3.9 µM). Therefore, it can be assumed that the NF-κB inhibitory activity of the dichloromethane and the ethyl acetate extracts is more driven by oroxylin A, although synergistic effects can never be ruled out. We also analyzed the content of the active flavonoids in four different Oroxylum indicum stem bark samples. The results (see Table 2) showed a strong variation in the different samples. In general, baicalein (0.13–0.45%) was the dominant flavonoid aglycone in the stem bark, followed by oroxylin A (0.09–0.14%).

Table 2.

Amount of individual flavonoids in the active extracts (DCM and EtOAc extracts) and stem bark materials of different Oroxylum indicum samples (Oro-1 to Oro-4). Values shown in w% of air-dried plant material and relative standard deviations are in parenthesis (n=3).

Hispidulin Baicalein Chrysin Oroxylin A Σ of flavonoids (%)
DCM extract n.d 13.43% 1.72% 8.56% 23.71
EtOAc extract 2.0% 15.96% 3.42% 13.83% 35.21
Oro-1 n.d 0.13% (4.36) 0.04% (1.43) 0.14% (3.92) 0.31
Oro-2 0.01% (4.50) 0.26% (4.87) 0.05% (4.28) 0.19% (2.86) 0.51
Oro-3 0.02% (1.19) 0.22% (4.46) 0.07% (1.22) 0.10% (1.11) 0.41
Oro-4 0.03% (1.89) 0.45% (3.32) 0.15% (5.01) 0.09% (4.74) 0.71
Open in a new tab

Oroxylum indicum is used in many Asian countries; however, different parts of the plant are often used. The seeds of Oroxylum indicum are described in the Chinese Pharmacopeia (The State Pharmacopoeia Commission of P.R. China, 2010) while the stem bark is present in the Vietnamese Pharmacopoeia (The State Pharmacopoeia Commission of Vietnamese Pharmacopoeia, 2009). In the Ayurvedic system of medicine, the root bark is the officially used part of Oroxylum indicum (Radhika et al., 2011). Due to the popularity of this herbal medicine, several analytical procedures have been reported for the detection of flavonoids in different plant parts. Interestingly, hispidulin was not detected in the seeds (Krüger and Ganzera, 2012), while all four compounds (hispidulin, baicalein, chrysin and oroxylin A) were detected simultaneously in the root bark (Yadav et al., 2012). Among the quantified flavonoids, baicalein was the dominant flavonoid aglycone in all plant parts of Oroxylum indicum, 0.09–0.18% in the seeds (Krüger and Ganzera, 2012), 0.13–0.45% in the stem bark (Table 2), and 0.67% in the roots (Yadav et al., 2012).

4. Conclusion

Ethnopharmacological knowledge is a promising source for the selection of potential bioactive plant material. Among 17 Vietnamese plants used for the treatment of a variety of diseases associated with inflammation, the dichloromethane extracts of Chromolaena odorata and Oroxylum indicum proved to be promising inhibitors of the NF-κB pathway. A previous study identified fatty acids of Chromolaena odorata as inhibitors of NF-κB activation (Tran et al., 2011) but since the main constituents of this plant (Dat et al., 2009) are flavonoids, it might be necessary to consider a contribution of these compounds to the NF-κB inhibitory effect of this plant. Phytochemical studies of Oroxylum indicum bark led to the identification of four bioactive flavonoids (hispidulin, baicalein, chrysin, and oroxylin A). Baicalein and its glycoside, baicalin, are well known for their anti-inflammatory activity related to the inhibition of NF-κB activation. However, in this study, simultaneous testing with other constituents of Oroxylum indicum, baicalein showed a weak activity while baicalin was inactive, whereas other flavonoids e.g. oroxylin A seem to be more important in respect to the NF-κB inhibitory effect of Oroxylum indicum extracts. Altogether, the performed study supports the traditional use of some of the investigated species against inflammation by the found in vitro activity and identified the stem bark of Oroxylum indicum as a valuable source of flavonoids with an anti-inflammatory activity.

Acknowledgments

The authors wish to thank the Austria Federal Ministry for Science and Research for financing a scholarship in frame of ASEA-Uninet granted by OeAD, and the Austrian Science Fund (FWF): S10703 and S10704 (NFN “Drugs from Nature Targeting Inflammation”) for the financial support. The authors gratefully acknowledge the expert technical assistance of M. Gössinger, as well as N. Engels for language corrections.

Appendix A. Supporting information

Supplementary data associated with this article can be found in the online version at doi:10.1016/j.jep.2014.10.012.

Appendix A. Supplementary materials

Supplementary data

mmc1.docx (118.1KB, docx)

References

  1. Allavena P., Garlanda C., Borrello M.G., Sica A., Mantovani A. Pathways connecting inflammation and cancer. Current Opinion in Genetics & Development. 2008;18:3–10. doi: 10.1016/j.gde.2008.01.003. [DOI] [PubMed] [Google Scholar]
  2. Baumgartner L., Sosa S., Atanasov A.G., Bodensieck A., Fakhrudin N., Bauer J., Favero G.D., Ponti C., Heiss E.H., Schwaiger S., Ladurner A., Widowitz U., Loggia R.D., Rollinger J.M., Werz O., Bauer R., Dirsch V.M., Tubaro A., Stuppner H. Lignan derivatives from Krameria lappacea roots inhibit acute inflammation in vivo and pro-inflammatory mediators in vitro. Journal of Natural Products. 2011;74:1779–1786. doi: 10.1021/np200343t. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bremner P., Heinrich M. Natural products as targeted modulators of the nuclear factor-kB pathway. Journal of Pharmacy and Pharmacology. 2002;54:453–472. doi: 10.1211/0022357021778637. [DOI] [PubMed] [Google Scholar]
  4. Bremner P., Heinrich M. Natural products and their role as inhibitors of the pro-inflammatory transcription factor NF-κB. Phytochemistry Reviews. 2005;4:27–37. [Google Scholar]
  5. Calixto J.B., Otuki M.F., Santos A.R.S. Anti-inflammatory compounds of plant origin. Part I. Action on arachidonic acid pathway, nitric oxide and nuclear factor κB (NF-κB) Planta Medica. 2003;69:973–983. doi: 10.1055/s-2003-45141. [DOI] [PubMed] [Google Scholar]
  6. Chen C.-C., Chow M.-P., Huang W.-C., Lin Y.-C., Chang Y.-J. Flavonoids inhibit tumor necrosis factor-α-induced up-regulation of intercellular adhesion molecule-1 (ICAM-1) in respiratory epithelial cells through activator protein-1 and nuclear factor-κB: structure–activity relationships. Molecular Pharmacology. 2004;66:683–693. doi: 10.1124/mol.66.3.. [DOI] [PubMed] [Google Scholar]
  7. Chen L.-J., Games D.E., Jones J. Isolation and identification of four flavonoid constituents from the seeds of Oroxylum indicum by high-speed counter-current chromatography. Journal of Chromatography A. 2003;988:95–105. doi: 10.1016/s0021-9673(02)01954-4. [DOI] [PubMed] [Google Scholar]
  8. Chen Y.-C., Yang L.-L., Lee T.J.F. Oroxylin A inhibition of lipopolysaccharide-induced iNOS and COX-2 gene expression via suppression of nuclear factor-κB activation. Biochemical Pharmacology. 2000;59:1445–1457. doi: 10.1016/s0006-2952(00)00255-0. [DOI] [PubMed] [Google Scholar]
  9. Dat N.T., Lee K., Hong Y.-S., Ho Kim Y., Van Minh C., Joon Lee J. A peroxisome proliferator-activated receptor-gamma agonist and other constituents from Chromolaena odorata. Planta Medica. 2009;75:803–807. doi: 10.1055/s-0029-1185386. [DOI] [PubMed] [Google Scholar]
  10. Eppihimer M.J. The role of leukocyte-endothelial cell adhesion in cardiovascular disease. Pathophysiology. 1998;5:167–184. [Google Scholar]
  11. Gupta S.C., Sundaram C., Reuter S., Aggarwal B.B. Inhibiting NF-κB activation by small molecules as a therapeutic strategy. Biochimica et Biophysica Acta (BBA)—Gene Regulatory Mechanisms. 2010;1799:775–787. doi: 10.1016/j.bbagrm.2010.05.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Johnson-Lyles D.N., Peifley K., Lockett S., Neun B.W., Hansen M., Clogston J., Stern S.T., McNeil S.E. Fullerenol cytotoxicity in kidney cells is associated with cytoskeleton disruption, autophagic vacuole accumulation, and mitochondrial dysfunction. Toxicology and Applied Pharmacology. 2010;248:249–258. doi: 10.1016/j.taap.2010.08.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Kang B.Y., Chung S.W., Kim S.H., Cho D., Kim T.S. Involvement of nuclear factor-κB in the inhibition of interleukin-12 production from mouse macrophages by baicalein, a flavonoid in Scutellaria baicalensis. Planta Medica. 2003;69:687–691. doi: 10.1055/s-2003-42779. [DOI] [PubMed] [Google Scholar]
  14. Kim S.-J., Moon Y.-J., Lee S.-M. Protective effects of baicalin against ischemia/reperfusion injury in rat liver. Journal of Natural Products. 2010;73:2003–2008. doi: 10.1021/np100389z. [DOI] [PubMed] [Google Scholar]
  15. Krüger A., Ganzera M. Oroxylum indicum seeds—analysis of flavonoids by HPLC-MS. Journal of Pharmaceutical and Biomedical Analysis. 2012;70:553–556. doi: 10.1016/j.jpba.2012.05.005. [DOI] [PubMed] [Google Scholar]
  16. Libby P., Ridker P.M., Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–1143. doi: 10.1161/hc0902.104353. [DOI] [PubMed] [Google Scholar]
  17. Ma Z., Otsuyama K.-i., Liu S., Abroun S., Ishikawa H., Tsuyama N., Obata M., Li F.-J., Zheng X., Maki Y., Miyamoto K., Kawano M.M. Baicalein, a component of Scutellaria radix from Huang-Lian-Jie-Du-Tang (HLJDT), leads to suppression of proliferation and induction of apoptosis in human myeloma cells. Blood. 2005;105:3312–3318. doi: 10.1182/blood-2004-10-3915. [DOI] [PubMed] [Google Scholar]
  18. Markasz L., Stuber G., Vanherberghen B., Flaberg E., Olah E., Carbone E., Eksborg S., Klein E., Skribek H., Szekely L. Effect of frequently used chemotherapeutic drugs on the cytotoxic activity of human natural killer cells. Molecular Cancer Therapeutics. 2007;6:644–654. doi: 10.1158/1535-7163.MCT-06-0358. [DOI] [PubMed] [Google Scholar]
  19. Mat Ali R., Houghton P.J., Raman A., Hoult J.R.S. Antimicrobial and antiinflammatory activities of extracts and constituents of Oroxylum indicum (L.) Vent. Phytomedicine. 1998;5:375–381. doi: 10.1016/S0944-7113(98)80020-2. [DOI] [PubMed] [Google Scholar]
  20. Nakamura N., Hayasaka S., Zhang X.-Y., Nagaki Y., Matsumoto M., Hayasaka Y., Terasawa K. Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-κb binding activities induced by interleukin-1β in human retinal pigment epithelial cell line. Experimental Eye Research. 2003;77:195–202. doi: 10.1016/s0014-4835(03)00116-7. [DOI] [PubMed] [Google Scholar]
  21. National Institute of Medicinal Materials . National Istitute of Medicinal Materials; Hanoi: 2004. Medicinal Plants and Animals, Science and Technology. [Google Scholar]
  22. Nguyen M.H., Vu V.D., Nguyen V.S., Hoang V.T., Nguyen H.D., Pham N.T., Than T.H., Doan C. CRES/FPD/UNEP/CITES/IUED; Hanoi, Vietnam: 2007. Report on the Review of Vietnam׳s Wildlife Trade Policy. [Google Scholar]
  23. Nguyen H.N., You Y.J. NF-kB inhibitory activities of the methanol extracts and some constituents therein of some Vietnamese medicinal plants. Scientia Pharmaceutica. 2009;77:389–399. [Google Scholar]
  24. Radhika L.G., Meena C.V., Peter S., Rajesh K.S., Rosamma M.P. Phytochemical and antimicrobial study of Oroxylum indicum. Ancient Science of Life. 2011;30:114–120. [PMC free article] [PubMed] [Google Scholar]
  25. Sacca R., Cuff C.A., Ruddle N.H. Mediators of inflammation. Current Opinion in Immunology. 1997;9:851–857. doi: 10.1016/s0952-7915(97)80189-6. [DOI] [PubMed] [Google Scholar]
  26. Sala E., Guasch L., Iwaszkiewicz J., Mulero M., Salvadó M.-J., Bladé C., Ceballos M., Valls C., Zoete V., Grosdidier A., Garcia-Vallvé S., Michielin O., Pujadas G. Identification of human IKK-2 inhibitors of natural origin (Part II): in silico prediction of IKK-2 inhibitors in natural extracts with known anti-inflammatory activity. European Journal of Medicinal Chemistry. 2011;46:6098–6103. doi: 10.1016/j.ejmech.2011.09.022. [DOI] [PubMed] [Google Scholar]
  27. Shin E.K., Kwon H.-S., Kim Y.H., Shin H.-K., Kim J.-K. Chrysin, a natural flavone, improves murine inflammatory bowel diseases. Biochemical and Biophysical Research Communications. 2009;381:502–507. doi: 10.1016/j.bbrc.2009.02.071. [DOI] [PubMed] [Google Scholar]
  28. Shin S.Y., Woo Y., Hyun J., Yong Y., Koh D., Lee Y.H., Lim Y. Relationship between the structures of flavonoids and their NF-κB-dependent transcriptional activities. Bioorganic & Medicinal Chemistry Letters. 2011;21:6036–6041. doi: 10.1016/j.bmcl.2011.08.077. [DOI] [PubMed] [Google Scholar]
  29. Siriwatanametanon N., Fiebich B.L., Efferth T., Prieto J.M., Heinrich M. Traditionally used Thai medicinal plants: in vitro anti-inflammatory, anticancer and antioxidant activities. Journal of Ethnopharmacology. 2010;130:196–207. doi: 10.1016/j.jep.2010.04.036. [DOI] [PubMed] [Google Scholar]
  30. Stern S.T., Zolnik B.S., McLeland C.B., Clogston J., Zheng J., McNeil S.E. Induction of autophagy in porcine kidney cells by quantum dots: a common cellular response to nanomaterials? Toxicological Sciences. 2008;106:140–152. doi: 10.1093/toxsci/kfn137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sun Z., Andersson R. NF-[kappa]B activation and inhibition: a review. Shock. 2002;18:99–106. doi: 10.1097/00024382-200208000-00001. [DOI] [PubMed] [Google Scholar]
  32. The State Pharmacopoeia Commission of P.R. China . China Medical Science Press; Beijing: 2010. Pharmacopoeia of People׳s Republic of China; p. 304. [Google Scholar]
  33. The State Pharmacopoeia Commission of Vietnamese Pharmacopoeia . Pharmacopoeia of Vietnam. Vietnam Medicinal Science Press; Hanoi: 2009. p. 856. [Google Scholar]
  34. Tran T.H.H., Dan T.T.H., Minh C.V., Dat N.T. Anti-inflammatory effects of fatty acids isolated from Chromolaena odorata. Asian Pacific Journal of Tropical Medicine. 2011;4:760–763. doi: 10.1016/S1995-7645(11)60189-2. [DOI] [PubMed] [Google Scholar]
  35. Vogl S., Atanasov A.G., Binder M., Bulusu M., Zehl M., Fakhrudin N., Heiss E.H., Picker P., Wawrosch C., Saukel J., Reznicek G., Urban E., Bochkov V., Dirsch V.M., Kopp B. The herbal drug melampyrum pratense L. (Koch): isolation and identification of its bioactive compounds targeting mediators of inflammation. Evidence-Based Complementary and Alternative Medicine. 2013;2013:10. doi: 10.1155/2013/395316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wu S., Sun A., Liu R. Separation and purification of baicalin and wogonoside from the Chinese medicinal plant Scutellaria baicalensis Georgi by high-speed counter-current chromatography. Journal of Chromatography A. 2005;1066:243–247. doi: 10.1016/j.chroma.2005.01.054. [DOI] [PubMed] [Google Scholar]
  37. Xue X., Qu X.-J., Yang Y., Sheng X.-H., Cheng F., Jiang E.N., Wang J.-h., Bu W., Liu Z.-P. Baicalin attenuates focal cerebral ischemic reperfusion injury through inhibition of nuclear factor κB p65 activation. Biochemical and Biophysical Research Communications. 2010;403:398–404. doi: 10.1016/j.bbrc.2010.11.042. [DOI] [PubMed] [Google Scholar]
  38. Yadav A., Manika N., Bagchi G., Gupta M. Simultaneous determination of flavonoids in Oroxylum indicum by RP-HPLC. Medicinal Chemistry Research. 2012:1–6. [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary data

mmc1.docx (118.1KB, docx)

RESOURCES